...
首页> 外文期刊>Biotechnology Law Report >Judgment in Human Genome Sciences Inc. (Appellant) v. Eli Lilly and Company (Respondent) Before Lord Hope, Deputy President, Lord Walker, Lord Neuberger, Lord Clarke, and Lord Collins [extract]
【24h】

Judgment in Human Genome Sciences Inc. (Appellant) v. Eli Lilly and Company (Respondent) Before Lord Hope, Deputy President, Lord Walker, Lord Neuberger, Lord Clarke, and Lord Collins [extract]

机译:人类基因组科学公司(上诉人)对礼来公司的诉状(被告)在希望勋爵,副总统,沃克勋爵,诺伊贝格尔勋爵,克拉克勋爵和柯林斯勋爵[摘录]之前

获取原文
获取原文并翻译 | 示例
           

摘要

1. This appeal is concerned with the validity of a patent which claims the nucleotide sequence of the gene which encodes for a novel protein (and which has further associated claims). Although there is an insufficiency issue,... the primary issue on this appeal [is] the way in which the requirement of industrial applicability in Articles 52 and 57 of the European Patent Convention extends to a patent for biological material.
机译:1,本申请涉及要求专利的有效性,该专利要求编码新蛋白质的基因的核苷酸序列(并具有进一步的相关权利要求)。尽管存在供不应求的问题,但是……此上诉的主要问题[是]《欧洲专利公约》第52条和第57条对工业适用性的要求扩展到了生物材料专利的方式。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号